Transcode Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Transcode Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2020 to Q3 2024.
  • Transcode Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 14.7M shares, a 13322% increase year-over-year.
  • Transcode Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 179K shares, a 1003% increase from 2022.
  • Transcode Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 16.2K shares, a 99.8% decline from 2021.
  • Transcode Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 8.43M shares, a 81.7% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 14.7M +14.6M +13322% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 7.05M +7.02M +23023% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 5.14M +5.12M +27558% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 179K +163K +1003% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 109K -539K -83.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 30.5K -618K -95.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 18.6K -13M -99.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 16.2K -8.41M -99.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 649K -10.9M -94.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 649K -3.99M -86% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 13M +8.34M +180% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 8.43M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 11.5M +6.89M +149% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 4.64M 0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 4.64M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 4.64M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 4.64M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.